Advertisement
To participate in the event by telephone, please dial (888) 241-0558 fiveto 10 minutes prior to the start time (to allow time for registration) andreference the conference ID 33078994. International callers should dial (647)427-3417.
Advertisement
A digital replay of the call will be available on Wednesday, February 13at approximately 11:00 a.m. EST through Wednesday, February 20 at midnight EST.To listen to the replay, dial (800) 839-4177 and enter the conference IDnumber 33078994. International callers should dial (402) 220-2901 and enterthe same conference ID number.
The conference call will also be webcast live over the Internet and can beaccessed by all interested parties at the company's Web site,http://www.chn-biotics.com .
To monitor the live webcast, please go to this web site at least 15minutes prior to the start of the call to register, download, and install anynecessary audio software. An audio replay of the event will be archived onChina-Biotics' Web site at http://www.chn-biotics.com/ for 90 days.
About China-Biotics, Inc.
Headquartered in Shanghai, China-Biotics, Inc. ("China-Biotics", "theCompany") was founded in 1999 and is one of China's largest suppliers ofprobiotics. Probiotics are beneficial live bacteria used as dietarysupplements and food additives to improve intestinal health and digestion. TheCompany's product portfolio contains live microbials made with proprietarytechnology. Currently, these products are sold over-the-counter under the"Shining" brand through large distributors to more than 1,000 pharmacies and100 supermarkets in Shanghai, Jiangsu and Zhejiang. Shining is one of the mostrecognized brands in Shanghai. China-Biotics plans to expand its retail salesto other major cities in China and will launch 300 Shining brand logisticcenters in these cities during the next two years. The Company's flagshipproduct, "Shining Essence", has been a profit driver since its launch in April2001. There is a significant demand for probiotics for use in the bulkadditive market, which is currently met by imports. China-Biotics is buildinga new plant which will increase its production capacity manifolds to capturethis market. For more information, please visit http://www.chn-biotics.com .
Safe Harbor Statement Under the Private Securities Litigation Reform Actof 1995: Any statements set forth above that are not historical facts areforward-looking statements that involve risks and uncertainties that couldcause actual results to differ materially from those in the forward-lookingstatements. Such factors include, but are not limited to, the Company'sability to market existing and new products, ability to access to capital forexpansion, and changes from anticipated levels of sales, future national orregional economic and competitive conditions, changes in relationships withcustomers, dependence on its flagship product profits and other factorsdetailed from time to time in the Company's filings with the United StatesSecurities and Exchange Commission and other regulatory authorities. TheCompany undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events orotherwise.For more information, please contact: CCG Elite Investor Relations Crocker Coulson, President Tel: +1-646-213-1915 (New York) Email: [email protected]
SOURCE China-Biotics, Inc.
